Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS
Proper management of multiple sclerosis (MS) treatment requires feedback from clinical practice provided by registries. This article focuses on the introduction of the Czech national multiple sclerosis registry, ReMuS, and examines the availability and use of drugs...